RFA联合TACE治疗合并肝硬化的早期肝细胞肝癌的疗效研究

摘要

目的：评估射频消融术( RFA)联合肝动脉化疗栓塞术( TACE)与单独射频消融术治疗合并肝硬化的早期肝细胞癌(HCC)的疗效。方法回顾性分析2008年1月至2013年12月在我院行RFA(n=53)和RFA+TACE(n=51)患者的临床资料,对2组患者人口统计学资料、手术过程、术后并发症、术后恢复情况及随访情况进行比较。结果随访(37.6±12.3)个月,76例生存,38例死亡。 RFA+TACE组和RFA组的1年、3年、5年无瘤生存率分别为75.4%、47.3%、32.6%和63.1%、37.2%、22.4%。RFA+TACE组和RFA组的1年、3年、5年总生存率分别为96.5%、78.7%、65.9%和94.3%、75.6%、62.3%。结论对于合并肝硬化早期肝癌患者,RFA+TACE治疗比单独使用RFA治疗具有更高的无瘤生存率,而总体生存率无差异。%Objective To assess the effect of radiofrequency ablation ( RFA) combined with transcatheter hepatic arterial chemoemboli-zation ( TACE) and radiofrequency ablation alone for the treatment of early hepatocellular carcinoma ( HCC) with liver cirrhosis. Methods The data of all the patients that were given RFA+TACE (n=51) and RFA (n=53) treatments in our hospital from January 2008 to De-cember 2013 were analyzed. The demographic data,process of operation,postoperative complications,postoperative recovery and follow-up of the patients in two groups were carefully compared. Results The average follow-up time was (37. 6 ± 20. 7)months,38 cases were dead and 76 cases were survival. The overall survival rates of 1 years,3 years,5 years after operation were respectively 96. 5%,78. 7%,65. 9% in RFA+TACE group and 94. 3%,75. 6%,62. 3% in RFA group. Tumor-free survival rates of 1 years,3 years,5 years were 75. 4%,47. 3%, 32. 6% in RFA+TACE group,and 63. 1%,37. 2%,22. 4% in RFA group. Conclusion For patients with early hepatocellular carcinoma with liver cirrhosis,RFA combined with TACE have higher tumor free survival rate than RFA alone in the treatment of early hepatocellular carcinoma,but no difference in overall survival rate. The results still need to be validated by prospectively randomized controlled trials.